
    
      This study is a multi-center, prospective, randomized, double-blinded, sham-controlled,
      within-subject design, 3-treatment, 3-period cross-over study involving 38 subjects with
      Parkinson's Disease who have the wearing-off phenomenon on oral levodopa therapy. All
      participants will receive three treatments on different days, each with different stimulation
      conditions. All subjects will wear the Earstim device on the ear ipsilateral to the side of
      the body more affected by Parkinson's Disease for 120 minutes during each of the three
      treatment applications.
    
  